Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. NZ501251 - Sertraline salts and sustained-release dosage forms of sertraline

Office Nouvelle-Zélande
Numéro de la demande 501251
Date de la demande 15.06.1998
Numéro de publication 501251
Date de publication 28.09.2001
Numéro de délivrance
Date de délivrance 10.01.2002
Type de publication B
CIB
A61K 31/135
ANÉCESSITÉS COURANTES DE LA VIE
61SCIENCES MÉDICALE OU VÉTÉRINAIRE; HYGIÈNE
KPRÉPARATIONS À USAGE MÉDICAL, DENTAIRE OU POUR LA TOILETTE
31Préparations médicinales contenant des ingrédients actifs organiques 
13Amines, p.ex. amantadine
135ayant des cycles aromatiques, p.ex. méthadone
CPC
A61K 9/0004
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
A61K 9/1652
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
16Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
1605Excipients; Inactive ingredients
1629Organic macromolecular compounds
1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
A61K 9/2009
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2004Excipients; Inactive ingredients
2009Inorganic compounds
A61K 9/2013
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2004Excipients; Inactive ingredients
2013Organic compounds, e.g. phospholipids, fats
A61K 9/2018
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2004Excipients; Inactive ingredients
2013Organic compounds, e.g. phospholipids, fats
2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
A61K 9/2054
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2004Excipients; Inactive ingredients
2022Organic macromolecular compounds
205Polysaccharides, e.g. alginate, gums; Cyclodextrin
2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Déposants PFIZER INC.
Inventeurs Am Ende, Mary Tanya
Curatolo, William John
Friedman, Hylar Lewis
Shanker, Ravi Mysore
Herbig, Scott Max
Friesen, Dwayne Thomas
West, James Blair
Mandataires AJ PARK
Données relatives à la priorité 97 51402 01.07.1997 US
97 51414 01.07.1997 US
97 51420 01.07.1997 US
97 51498 01.07.1997 US
Titre
(EN) Sertraline salts and sustained-release dosage forms of sertraline
Abrégé
(EN)
Patent 501251 Sustained release dosage forms of sertraline, or pharmaceutically acceptable salts thereof are disclosed. Sertraline is released at a rate of between 0.02 mgA/hr/kg and 0.6 mgA/hr/kg, or between 1 mgA/hr and 40 mgA/hr, where mgA is the amount of active sertraline. The dosage form must not release more than 70% of the sertraline in the first hour following administration. The dosage form is suitable for oral administration to a mammal.